Michelle Callegan to Ciprofloxacin
This is a "connection" page, showing publications Michelle Callegan has written about Ciprofloxacin.
Connection Strength
0.547
-
In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens. Cornea. 2000 Jul; 19(4):539-45.
Score: 0.177
-
Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Invest Ophthalmol Vis Sci. 1994 Mar; 35(3):1033-7.
Score: 0.114
-
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 1992 Oct; 33(11):3017-23.
Score: 0.104
-
Pharmacokinetics of topically applied ciprofloxacin in rabbit tears. Jpn J Ophthalmol. 1996; 40(1):123-6.
Score: 0.032
-
The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn J Ophthalmol. 1996; 40(2):212-9.
Score: 0.032
-
Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993 May; 12(5):469-73.
Score: 0.027
-
Bioassays for quantitating ciprofloxacin and tobramycin in aqueous humor. J Ocul Pharmacol. 1993; 9(4):311-20.
Score: 0.026
-
Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin. Curr Eye Res. 1992 Nov; 11(11):1111-9.
Score: 0.026
-
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1995 Mar; 14(3):229-34.
Score: 0.008